Adderall

Adderall is a combination of dextroamphetamine and levoamphetamine that is commonly prescribed for ADHD. It effectively combats ADHD in many people, and in healthy users, it can provide an acute cognitive boost. Because of its cognition enhancing and stimulant properties, adderall is commonly used by students and workers.

In normal medical settings with a common medical dose, adderall doesn’t appear to be notably harmful and it appears useful (at least on a time scale of 1-2 years) in those with ADHD.

The drug can provide wakefulness and improve attentiveness, motivation, cognitive performance, and physical performance. Outside of medical settings, tolerance will usually kick in quickly and remove many of the beneficial effects.

Adderall = Amphetamine; Adderall XR

Dose

Oral

Light: 5 – 15 mg

Common: 15 – 40 mg

Strong: 40 – 75 mg

Intranasal

Light: 5 – 10 mg

Common: 10 – 30 mg

Strong: 30 – 50 mg

Timeline

Oral

Total: 3 – 5 hours (extended to 6 – 10 hours with Adderall XR)

Onset: 00:10 – 00:30 (extended to 00:20 – 01:00 with Adderall XR)

Intranasal

Total: 2 – 4 hours

Onset: 00:01 – 00:05

Experience Reports

Erowid

References

(2016) Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents

(2014) Psychostimulants and Cognition: A Continuum of Behavioral and Cognitive Activation

(2014) Pharmacological interventions for adolescents and adults with ADHD: stimulant and nonstimulant medications and misuse of prescription stimulants

(2013) Meta-analysis of Functional Magnetic Resonance Imaging Studies of Inhibition and Attention in Attention-deficit/Hyperactivity Disorder

(2013) Effect of Psychostimulants on Brain Structure and Function in ADHD: A Qualitative Literature Review of MRI-Based Neuroimaging Studies

(2013) Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management

(2013) The long-term outcomes of interventions for the management of attention-deficit hyperactivity disorder in children and adolescents: a systematic review of randomized controlled trials

(2013) Amphetamine, past and present – a pharmacological and clinical perspective

(2012) A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment

(2011) Meta-analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects

(2011) Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults

(2011) ADHD Drugs and Serious Cardiovascular Events in Children and Young Adults

(2009) Potential adverse effects of amphetamine treatment on brain and behavior: a review

(2004) Combining Stimulants With Monoamine Oxidase Inhibitors: A Review of Uses and One Possible Additional Indication

(1974) Long-term administration of d-amphetamine: Progressive augmentation of motor activity and stereotypy

(1957) Amphetamine Psychosis

Test Results